A novel small molecule glycolysis inhibitor WZ35 exerts anti-cancer effect via metabolic reprogramming

BACKGROUND: Liver cancer is the fifth leading cause of cancer death worldwide, but early diagnosis and treatment of liver cancer remains a clinical challenge. How to screen and diagnose liver cancer early and prolong the survival rate is still the focus of researchers. METHODS: Cell experiments were...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lihua, Zhu, Zheng, Liang, Qi, Tao, Yecheng, Jin, Gaowei, Zhong, Yaoyao, Dai, Jichen, Dai, Ruixia, Wang, Zhixiang, Chen, Junbo, Zhou, Lingjie, Ke, Shouyu, Zheng, Bin, Lan, Linhua, Lin, Xiaokun, Chen, Tongke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673307/
https://www.ncbi.nlm.nih.gov/pubmed/36401321
http://dx.doi.org/10.1186/s12967-022-03758-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673307/
https://www.ncbi.nlm.nih.gov/pubmed/36401321
http://dx.doi.org/10.1186/s12967-022-03758-0

Ejemplares similares